“A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis”, AJPS, vol. 7, no. 1, pp. 90–105, Jun. 2010, doi: 10.32947/ajps.v7i1.321.